Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Novo Nordisk

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood

Ministers have announced plans which could see tens of thousands given access to new weight-loss drug

The Independent UK

Why You Should Go Overweight On Novo Nordisk Stock

Novo Nordisk is already the global kingpin in diabetes treatments, with about 30% of the $50+ billion global diabetes market and around half of the $20 billion insulin therapy market. Now, it is becoming a powerhouse in weight-loss drugs, thanks to its Wegovy drug.

Barchart

Watch out for Ozempic copycats containing unauthorized active ingredients, FDA warns

Some compounding pharmacies are using unauthorized active ingredients to make copycat versions of Ozempic and Wegovy.

LiveScience

From analysis to the latest developments in health,
read the most diverse news in one place.

Friday briefing: Are appetite-suppressing drugs really a fast track to weight loss?

In today’s newsletter: Semaglutide has won endorsements from celebrities and expert drugs advisers and has gone viral on TikTok. But don’t expect a quick fix

The Guardian - UK

Families scramble to find growth hormone drug as shortage drags on

Children who need growth hormone to achieve their full stature are having trouble getting the medicine. A shortage has stretched months longer than expected and could last the rest of the year.

WEKU

WHO issues warning on weight loss drugs

Balanced diet and exercise remain key to losing weight, health body says

The Independent UK

Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review

New highly-effective weight loss drugs such as Novo Nordisk's Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years.

Reuters

Read news from The Economist, FT, and more,
with one subscription

What's behind shortages of Adderall, Ozempic and other meds?

Drug shortages are growing in the United States, and experts see no clear path to resolving them

The Independent UK

Can drugs fix the UK’s adolescent obesity crisis?

A powerful new weight-loss medication may be approved for those aged 12 to 17. But healthcare professionals fear it ignores the underlying socioeconomic causes

The Guardian - UK

Children could be prescribed weight-loss jabs on the NHS

Department of Health asks watchdog to assess effectiveness of giving semaglutide to obese youngsters aged 12 to 17

The Guardian - UK

Doctors issue urgent warning over diabetes drug Ozempic being sold on Facebook Marketplace

The alert comes after an increased number of social media posts, in which users are marketing the drug as a rapid weight loss solution

Chronicle Live

Social Media adds to weight loss craze

GLP-1 agonists are a class of weight loss drug that is going viral on social media — but misinformation is rife

Salon

A ‘skinny jab’ is no quick fix for obesity – and no excuse to let junk food companies off the hook

Britain should be taxing unhealthy food and clamping down on marketing, says Sarah Boseley, the Guardian’s former health editor

The Guardian - UK

Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?

Suzette Zuena is her own best advertisement for weight loss.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Chicago Sun-Times

Experts warn new weight loss medications carry long-term concerns

Some doctors, psychologists and eating disorder experts worry these new medications, originally developed to treat diabetes, could become a problem long-term.

Marie Claire

So, is Wegovy the same as Ozempic? Your need-to-knows about the controversial over-the-counter weight loss drugs

Two experts explain.

The Guardian - UK

Revealed: maker of Wegovy ‘skinny jab’ is funding NHS weight-loss services

Critics fear conflict of interest as Novo Nordisk helps medics ‘reduce unnecessary barriers’ to treatment for obesity

Reuters

EU backs use of Novo Nordisk's weight loss drug in adolescents

The European Medicines Agency said on Friday its committee has recommended expanding the use of Danish drugmaker Novo Nordisk's weight loss drug in adolescents aged 12 years and older.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

How Investors are Capitalizing on the Ozempic and Wegovy Craze

Ozempic and Wegovy started as injectable diabetes treatments. But now, these “appetite suppressants” are being touted as miracle weight loss drugs.

StockNews.com

Stay Forever Young With These 3 Pharmaceutical Stocks

Despite macroeconomic headwinds, the pharmaceutical industry is anticipated to stay buoyed in the foreseeable future, owing to rising healthcare spending. Against this backdrop, we think the strong fundamentals of Novo Nordisk (NVO), Bristol-Myers Squibb (BMY), and Takeda Pharmaceutical (TAK) make them wise portfolio additions. Read on….

Evening Standard

WHO to consider adding obesity drugs to ‘essential’ medicines list

A panel of advisers to the WHO will review requests for drugs to be included next month

ABC News

Relief for diabetes sufferers with fast-acting insulin Fiasp to remain on PBS until September

Fast-acting insulin Fiasp has been a "game changer" for Daniel Webb in managing his type 1 diabetes. The drug was about to be removed from the PBS, but a temporary solution has been found.

The Guardian - UK

‘I skip meals to make my insulin last’: the cost of diabetes in the global south

The three firms that control the insulin market are to cut costs in the US, but elsewhere users can spend all their pay to get the life-saving drug

Los Angeles Times

Newsom announces $50 million contract to make California’s own brand of insulin

LOS ANGELES — California Gov. Gavin Newsom announced a new $50-million contract with the nonprofit generic drugmaker Civica to produce insulin under the state’s own label during a news conference Saturday in Downey.

The Guardian - UK

‘Skinny jab’ drug firm facing fresh inquiries after ‘serious breaches’ of industry code

Pharmaceutical company behind blockbuster diet jab Wegovy confronts crises on multiple fronts, amid scrutiny of UK activities

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations